CN Stock MarketDetailed Quotes

688331 RemeGen Co., Ltd.

Watchlist

28.03
-0.67-2.33%

Market Closed Jan 3 15:00 CST

15.26BMarket Cap-9.83P/E (TTM)

RemeGen Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RemeGen Co., Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 2.422B	--
--	2024/FY	-- / 1.727B	--
--	2023/FY	1.083B / 1.129B	--
Mar 30, 2023	2022/FY	772.109M / 870.124M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 2.422B--

--2024/FY-- / 1.727B--

--2023/FY1.083B / 1.129B--

Mar 30, 20232022/FY772.109M / 870.124M--

--------

Unlock Free Earnings Estimates

Open Account

RemeGen Co., Ltd. Earnings Reports

Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2024 Third Quarter Report

Oct 29, 2024 12:00 ET

Remegen Biopharmaceutical (Yantai) Co., Ltd. 2024 Semi-annual Report

Aug 16, 2024 12:00 ET

Summary of Remegen (Yantai) Co., Ltd.'s 2024 Interim Report

Aug 16, 2024 12:00 ET

Rongchang Biopharmaceutical (Yantai) Co., Ltd. 2024 First Quarter Report

Apr 26, 2024 12:00 ET

Analyst Rating

Updated: Jan 3, 2025

Strong Buy

Strong Buy
85.71%
Buy
7.14%
Hold
7.14%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall

No Data